Inventor
YANTHA JASON
CA28 patents
⚠️ This page may combine multiple inventors who share the name “YANTHA JASON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYN X PHARMA INC
14 patentsUS6890763B2May 10, 2005
Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
SYN X PHARMA INC79 citations98
US6627606B2Sep 30, 2003
Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons
SYN X PHARMA INC18 citations92
US6620786B2Sep 16, 2003
Biopolymer marker indicative of disease state having molecular weight of 2937 daltons
SYN X PHARMA INC19 citations92
US6617308B2Sep 9, 2003
Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons
SYN X PHARMA INC18 citations92
US6602855B2Aug 5, 2003
Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
SYN X PHARMA INC26 citations92
US6756476B2Jun 29, 2004
Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
SYN X PHARMA INC14 citations84
US6627608B2Sep 30, 2003
Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons
SYN X PHARMA INC15 citations84
US6620787B2Sep 16, 2003
Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons
SYN X PHARMA INC16 citations84
US6599877B2Jul 29, 2003
Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons
SYN X PHARMA INC13 citations84
US6593298B2Jul 15, 2003
Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons
SYN X PHARMA INC16 citations84
US6627607B2Sep 30, 2003
Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons
SYN X PHARMA INC12 citations74
US7049397B2May 23, 2006
Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
SYN X PHARMA INC4 citations63
US7087435B2Aug 8, 2006
Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
SYN X PHARMA INC0 citations52
US6998243B2Feb 14, 2006
Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
SYN X PHARMA INC1 citations52
JACKOWSKI GEORGE
5 patentsUS9119826B2Sep 1, 2015
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
JACKOWSKI GEORGE2 citations58
US8715648B2May 6, 2014
Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
JACKOWSKI GEORGE3 citations58
US8263351B2Sep 11, 2012
Diagnostic methods for congestive heart failure
JACKOWSKI GEORGE0 citations45
US8951514B2Feb 10, 2015
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
JACKOWSKI GEORGE0 citations37
US8952000B2Feb 10, 2015
Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
JACKOWSKI GEORGE0 citations37
ARTEMIS PROTEOMICS LTD
3 patentsUS7229638B2Jun 12, 2007
Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons
ARTEMIS PROTEOMICS LTD0 citations49
US7125726B2Oct 24, 2006
Method and kit for diagnosing myocardial infarction
ARTEMIS PROTEOMICS LTD1 citations49
US7008800B2Mar 7, 2006
Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
ARTEMIS PROTEOMICS LTD0 citations49